Front Row Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6
Closed -$1.32K 797
2024
Q2
$1.32K Hold
6
﹤0.01% 878
2024
Q1
$1.35K Buy
+6
New +$1.35K ﹤0.01% 868
2023
Q4
Sell
-6
Closed -$1.32K 765
2023
Q3
$1.32K Hold
6
﹤0.01% 849
2023
Q2
$1K Hold
6
﹤0.01% 870
2023
Q1
$1K Hold
6
﹤0.01% 891
2022
Q4
$1K Sell
6
-15
-71% -$2.64K ﹤0.01% 865
2022
Q3
$4K Sell
21
-11
-34% -$2.24K ﹤0.01% 719
2022
Q2
$7K Sell
32
-4
-11% -$902 ﹤0.01% 599
2022
Q1
$9K Hold
36
﹤0.01% 578
2021
Q4
$9K Hold
36
﹤0.01% 616
2021
Q3
$7K Hold
36
﹤0.01% 667
2021
Q2
$8K Buy
36
+6
+20% +$1.21K ﹤0.01% 629
2021
Q1
$6K Sell
30
-3
-9% -$557 ﹤0.01% 700
2020
Q4
$6K Hold
33
﹤0.01% 657
2020
Q3
$6K Sell
33
-10
-23% -$1.6K ﹤0.01% 655
2020
Q2
$7K Sell
43
-1
-2% -$152 ﹤0.01% 565
2020
Q1
$6K Sell
44
-10
-19% -$1.5K ﹤0.01% 595
2019
Q4
$8K Sell
54
-3
-5% -$440 0.01% 508
2019
Q3
$8K Buy
57
+12
+27% +$1.79K 0.01% 492
2019
Q2
$7K Hold
45
0.01% 520
2019
Q1
$6K Hold
45
﹤0.01% 548
2018
Q4
$5K Sell
45
-24
-35% -$2.68K ﹤0.01% 554
2018
Q3
$7K Hold
69
﹤0.01% 496
2018
Q2
$8K Hold
69
0.01% 496
2018
Q1
$6K Buy
+69
New +$6.27K ﹤0.01% 537

Other funds holding STE

Front Row Advisors's STE Position: Q3 2024 in Review

Front Row Advisors sold out of Steris (STE) in Q3 2024, closing a stake of 6 shares — an estimated $1.32K sold.

Front Row Advisors first reported a position in STE in Q1 2018 and held it in 25 quarters. The position peaked at $9K in Q1 2022. 759 funds tracked by Wall St. Rank hold STE as of Q3 2024.

  • Front Row Advisors reported no remaining Steris position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 6 Steris shares in Q3 2024, an estimated $1.32K.
  • Front Row Advisors first reported a position in Steris in Q1 2018 and held it in 25 quarters.
  • Front Row Advisors's Steris position peaked at $9K in Q1 2022.
  • 759 funds tracked by Wall St. Rank held Steris as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.